
Tirzepatide
10 mg · 20 mg
Dual-incretin reference for next-gen metabolic panels

GLP-1 receptor agonist analogue
Semaglutide is a long-acting GLP-1 receptor agonist analogue used globally as a reference in metabolic and incretin research. Supplied in 5 mg and 10 mg fills with a complete identity and purity dossier at ≥ 99.2% HPLC purity.
96 vials of 5 mg in current lot · ships in 24 h cold-chain
| Format | Lyophilized powder · 3 mL amber vial |
|---|---|
| Net content | 5 mg |
| Available sizes | 5 mg · 10 mg |
| CAS | 910463-68-2 |
| Molar mass | 4113.6 g/mol |
| Purity (HPLC) | ≥ 99.2% |
| Storage | Store at –20 °C. Cold-chain shipment included. |
Background reading on the analysis behind Semaglutide’s certificate.
Cagrilintide's dual amylin-calcitonin agonism and survodutide's GCGR/GLP-1 co-agonism compared: receptor dynamics, hepatic lipid flux, preclinical biomarkers, and research-grade handling.
AnalyticsA technical comparison of Semaglutide vs. Tirzepatide in research models. Explore receptor kinetics, structural biochemistry, and laboratory reconstitution data.
QualityPurity, identity, endotoxin, residual solvents — what each number on a peptide COA actually proves, and the four fields to check before you trust it.

10 mg · 20 mg
Dual-incretin reference for next-gen metabolic panels


5 mg · 10 mg
Long-acting amylin analogue for dual incretin panels